Public Release: 

Prescribing sunshine for multiple sclerosis?

Faculty of 1000

Could a holiday in the sun reduce the risk of developing multiple sclerosis? In a recent review for F1000 Medicine Reports, Bridget Bagert and Dennis Bourdette highlight recent advances in potential treatments.

Multiple sclerosis (MS) results from a failure of the body to recognize itself. The immune system attacks and destroys the sheath that protects nerve fibres, as if it were a foreign body or infection. Vitamin D, which is produced in the skin in response to natural sunlight, is an immune system regulator. This might explain why MS is less common in sunnier countries.

Giving MS sufferers vitamin D pills - or encouraging them to spend more time in the sun - might be a cheap and easy treatment. Bagert and Bourdette point out that oral vitamin D therapy is now in phase II clinical trials, to see how well it works and how much would be needed.

They say "The arrival of effective oral agents will give MS patients more therapeutic options and will be a major advance in the global effort to alter the natural history of this chronic disease".

###

Notes to Editors

1. Dennis Bourdette, Faculty Member for F1000 Medicine, is chairman of the Department of Neurology and director of the Multiple Sclerosis and Neuroimmunology Center at Oregon Health and Science University, USA. http://www.f1000medicine.com/member/1960374908161351

2. Bridget A Bagert is a member of the Department of Neurology, Louisiana State University Health Sciences Center, USA

3. The full text of this article is available at http://www.f1000medicine.com/reports/10.3410/m1-34/.

4. Please name F1000 Medicine Reports/Faculty of 1000 Medicine in any story you write. If you are writing for the web, please link to the website.

5. The F1000 Medicine Reports (ISSN 1757-5931) journal, http://www.f1000medicine.com/reports, publishes short commentaries by expert clinicians focussing on the most important studies identified by Faculty of 1000 Medicine that are likely to change clinical practice. The commentaries summarise the implications of important new research findings for clinicians.

6. Faculty of 1000 Medicine, www.f1000medicine.com, is a unique online service that helps you stay informed of high impact articles and access the opinions of global leaders in medicine. Our distinguished international faculty select and evaluate key articles across medicine, providing a rapidly updated, authoritative guide to the medical literature that matters.

7. Please contact Kathleen Wets, Director of Sales & Marketing, for a complimentary journalist subscription to Faculty of 1000 www.f1000.com (which includes F1000 Medicine Reports).

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.